The Footnote

Critical Review: Buerger‑Allen Exercises for Peripheral Arterial Disease (PAD)

Buerger‑Allen exercises (BAE) are a century‑old, posture‑cycling routine (elevate to pallor → dependency to reactive hyperaemia → rest). (1) Contemporary evidence does not demonstrate clinically meaningful benefit for PAD (e.g., walking distance, limb events, quality of life), and major 2024–2025 guidelines do not recommend BAE. (2–5,7) In advanced ischaemia (CLTI), repeated elevation can aggravate ischaemic pain. (6) For patients who cannot walk, viable alternatives include upper‑limb aerobic…

Author attribution not recorded

An outdated exercise routine in a book being crossed out by a modern clinician.

Executive Summary

Buerger‑Allen exercises (BAE) are a century‑old, posture‑cycling routine (elevate to pallor → dependency to reactive hyperaemia → rest). (1) Contemporary evidence does not demonstrate clinically meaningful benefit for PAD (e.g., walking distance, limb events, quality of life), and major 2024–2025 guidelines do not recommend BAE. (2–5,7) In advanced ischaemia (CLTI), repeated elevation can aggravate ischaemic pain. (6) For patients who cannot walk, viable alternatives include upper‑limb aerobic training (arm‑ergometry), structured resistance training, neuromuscular electrical stimulation (NMES) as an adjunct, and selective intermittent pneumatic compression (IPC) when revascularisation is not possible. (8–11)

Bottom line: Don’t use BAE to treat PAD. Use guideline‑directed therapy (risk‑factor control + structured exercise), consider alternative exercise modalities when ambulatory walking is impossible, and escalate for revascularisation when indicated. (2–4,7–11)

 

Background

BAE was popularised before modern trials, vascular imaging, and supervised exercise therapy (SET). The method seeks to exploit transient positional hyperaemia rather than exercise‑induced metabolic demand. Despite periodic nursing/physio teaching, robust efficacy data for PAD are lacking. (1)

Evidence Appraisal

Search impression: Most BAE studies are small, short‑term, and quasi‑experimental, often in hospitalised adults with diabetes rather than rigorously phenotyped PAD. Outcomes are usually surrogate perfusion metrics (e.g., ABI over days–weeks, capillary refill, skin temperature) instead of patient‑centred endpoints (walking distance, HRQoL, limb salvage, MACE/MALE). A handful of narrative reviews and low‑rigour meta‑analyses pool heterogeneous designs. No high‑quality trials show improvements in claudication distance or hard outcomes. (1,4,5)

Quality & consistency:

  • Study designs: pre–post or non‑randomised; limited blinding/control; small N; short follow‑up. (1)

  • Populations: frequently diabetic cohorts with mixed vascular status; limited PAD phenotyping. (1)

  • Outcomes: surrogate measures prone to variability; minimal data on functional capacity or events. (1,4,5)

  • External validity: uncertain; little replication in vascular/rehab journals with rigorous methods. (1,4,5)

Guideline position: 2024 AHA/ACC and 2024 ESVS guidelines endorse structured exercise therapy (supervised or structured home‑based) as core management for claudication, plus best medical therapy. BAE is not mentioned or recommended. (2,3)

Physiological Considerations

  • Exercise vs. posture: Exercise‑induced hyperaemia drives muscle conditioning, endothelial adaptations, and collateral function; posture‑induced reactive hyperaemia does not reproduce these training effects. (2–5)

  • CLTI caveat: In chronic limb‑threatening ischaemia, dependency often relieves rest pain; forced elevation to pallor can worsen symptoms and is counter‑therapeutic. Use Buerger’s test diagnostically—not as a treatment routine. (6)

Safety and Practical Risks

  • Potential worsening of pain/colour change with elevation in CLTI. (6)

  • Opportunity cost: substituting BAE may delay effective therapies (structured exercise, risk‑factor optimisation, revascularisation), with implications for limb and life. (2–5,7)

 

Non‑Ambulatory Scenarios (bed or wheelchair‑bound)

When walking SET is not possible, the goal is to maintain cardiovascular conditioning and peripheral perfusion stimulus via upper‑body or assisted modalities, while ensuring optimal medical therapy.

1) Wheelchair users (able to use arms)

Primary modality: Upper‑limb aerobic training (arm‑ergometry/arm‑crank).

  • Prescription (starter): 30–40 minutes per session, 3×/week, moderate intensity (RPE 12–14). Build from 10–15 minutes in intervals (e.g., 3–5 minutes on / 1–2 minutes easy), aiming for 30–40 minutes continuous over 4–6 weeks. (7–9)

  • Progression: Increase total time first, then workload. Include 2 short resistance sessions/week (bands or light weights) targeting shoulder/elbow flexors/extensors and trunk stabilisers (2–3 sets of 8–12 reps). (7)

  • Supervision: Prefer supervised/structured programs when available; track adherence (logs, HR, RPE). (7,8)

2) Bed‑bound patients

Adjuncts:

  • Neuromuscular electrical stimulation (NMES) of calf/footplate devices for passive contractions (e.g., 30–60 min/day as per device protocol). (10)

  • Gentle ankle pumps only in dependency (avoid elevation‑to‑pallor cycles). Prioritise frequent off‑loading, pressure‑area care, warmth, and daily skin checks. (6)

  • Intermittent pneumatic compression (IPC) may be considered palliatively in no‑option CLTI (pain/wound support), subject to vascular team input and device access. (11)

3) Positioning & escalation

  • Avoid prolonged leg elevation in ischaemic rest pain; encourage dependent positioning for comfort. (6)

  • Escalate rapidly for vascular imaging/revascularisation evaluation if rest pain or tissue loss persists despite optimisation. (2,3,6)

 

Guideline‑Directed Medical Therapy (GDMT) — essentials

  • Antithrombotic therapy: Single antiplatelet for most; consider rivaroxaban 2.5 mg bid + low‑dose aspirin in suitable patients to reduce MACE/MALE. (2,12)

  • Lipid lowering: High‑intensity statin ± non‑statin as needed to reach targets. (2,12)

  • Risk‑factor control: Hypertension, glycaemia, smoking cessation; vaccinations; diet and weight management. (2,12)

  • Foot protection: Education, daily inspection, prompt care for wounds, pressure‑redistribution. (2,3)

 

Practical Recommendation

Do not prescribe Buerger‑Allen exercises as PAD therapy. For ambulatory patients, refer to supervised/structured walking programs. For non‑ambulatory patients, implement arm‑ergometry–based aerobic training and consider NMES (and IPC selectively in no‑option CLTI) as adjuncts—never as replacements for GDMT or indicated revascularisation. (2–4,7–11)

 

References

1.      Thakur A, Sharma R, Sharma SK, Thakur K, Jelly P, et al. Effect of Buerger-Allen exercise on foot perfusion among patients with diabetes mellitus: a systematic review & meta-analysis. Diabetes Metab Syndr. 2022;16(2):102393. doi:10.1016/j.dsx.2022.102393. ScienceDirect

2.      2024 ACC/AHA Guideline for Lower Extremity PAD. Circulation. 2024. doi:10.1161/CIR.0000000000001251. ahajournals.org

3.      ESVS 2024 Clinical Practice Guidelines on Asymptomatic PAD & Intermittent Claudication. Eur J Vasc Endovasc Surg. 2024. Portail Vasculaire

4.      Lane R, Harwood A, Watson L, Leng GC. Exercise for intermittent claudication. Cochrane Database Syst Rev. 2017;(12):CD000990. doi:10.1002/14651858.CD000990.pub4. Cochrane LibrarySt Andrews Research Repository

5.      Parmenter B, et al. Supervised Exercise Therapy for Intermittent Claudication. Phys Ther. 2020;100(1):8–? Oxford Academic

6.      Chronic critical limb ischaemia: rest pain relieved by dependency (clinical review). Am Fam Physician. 1999;59(8):1899–1908. AAFP

7.      Bonaca MP. Exercise Therapy in Symptomatic Peripheral Artery Disease: Summary of Evidence. ACC Expert Analysis; 2025. American College of Cardiology

8.      2024 AHA/ACC PAD Guideline Slide Set (key recommendations incl. structured exercise). American Heart Association; 2024. professional.heart.org

9.      Magalhães S, Santos M, Viamonte S, et al. Effect of arm-ergometry vs treadmill supervised exercise on HRQoL and mental health: secondary outcomes from ARMEX. J Patient-Rep Outcomes. 2025;9:15. SpringerLink

10. Askew CD, et al. Foot-PAD Trial protocol: home-based footplate NMES for PAD. BMJ Open. 2025;15:e093162. BMJ Open

11. Moran PS, Teljeur C, Harrington P, Ryan M. Systematic review of intermittent pneumatic compression for critical limb ischaemia. Vasc Med. 2014;20(1):41–50. SAGE JournalsEurope PMC

Treat-to-implementation overview of Supervised Exercise Therapy for PAD. Circulation: Cardiovasc Qual Outcomes. 2019;12:e007953. ahajournals.org

Simplified complete reading view